Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| XOMA Royalty Corp | 326,601 | reported | 22 Mar 2016 | tx 141+1,442,475−602,654 |
| CRITICAL THERAPEUTICS INC | 114,303 | reported | 22 Mar 2006 | tx 37+1,313,644−721,336 |
| Viridian Therapeutics, Inc.\DE | 87,000 | reported | 06 Feb 2019 | tx 3+259,500 |
| BioAge Labs, Inc. | 5,433 | reported | 02 Mar 2026 | tx 23+419,196−218,392 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | EXERCISE | BioAge Labs, Inc. | 2,000 | 6.57 USD | |
| 02 Mar 2026 | SALE | BioAge Labs, Inc. | 7,433 | 20.30 USD | |
| 02 Mar 2026 | EXERCISE | BioAge Labs, Inc. | 5,433 | 4.11 USD | |
| 02 Mar 2026 | EXERCISE | BioAge Labs, Inc. | 5,433 | 0.00 USD | deriv |
| 02 Mar 2026 | EXERCISE | BioAge Labs, Inc. | 2,000 | 0.00 USD | deriv |
| 17 Feb 2026 | GRANT_AWARD | BioAge Labs, Inc. | 110,000 | 0.00 USD | deriv |
| 02 Feb 2026 | SALE | BioAge Labs, Inc. | 7,433 | 18.75 USD | |
| 02 Feb 2026 | EXERCISE | BioAge Labs, Inc. | 2,000 | 6.57 USD | |
| 02 Feb 2026 | EXERCISE | BioAge Labs, Inc. | 5,433 | 4.11 USD | |
| 02 Feb 2026 | EXERCISE | BioAge Labs, Inc. | 5,433 | 0.00 USD | deriv |
| 02 Feb 2026 | EXERCISE | BioAge Labs, Inc. | 2,000 | 0.00 USD | deriv |
| 02 Jan 2026 | SALE | BioAge Labs, Inc. | 7,433 | 12.85 USD | |
| 02 Jan 2026 | EXERCISE | BioAge Labs, Inc. | 2,000 | 6.57 USD | |
| 02 Jan 2026 | EXERCISE | BioAge Labs, Inc. | 5,433 | 4.11 USD | |
| 02 Jan 2026 | EXERCISE | BioAge Labs, Inc. | 5,433 | 0.00 USD | deriv |
| 02 Jan 2026 | EXERCISE | BioAge Labs, Inc. | 2,000 | 0.00 USD | deriv |
| 09 Dec 2025 | SALE | BioAge Labs, Inc. | 18,000 | 12.00 USD | |
| 09 Dec 2025 | EXERCISE | BioAge Labs, Inc. | 18,000 | 6.57 USD | |
| 09 Dec 2025 | EXERCISE | BioAge Labs, Inc. | 18,000 | 0.00 USD | deriv |
| 04 Dec 2025 | EXERCISE | BioAge Labs, Inc. | 68,897 | 4.11 USD | |
| 04 Dec 2025 | SALE | BioAge Labs, Inc. | 68,897 | 10.19 USD | |
| 04 Dec 2025 | EXERCISE | BioAge Labs, Inc. | 68,897 | 0.00 USD | deriv |
| 18 Feb 2025 | GRANT_AWARD | BioAge Labs, Inc. | 200,000 | 0.00 USD | deriv |
| 06 Feb 2019 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 87,000 | 0.00 USD | deriv |
| 31 Jan 2018 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 85,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 30 Sept 2013.